Rapidly increasing maternal morbidity and death continue to be mostly attributed to cardiovascular disease. Whenever both the pregnant woman and the developing foetus are exposed to several possible difficulties, various physiological changes of gestation happen. Women who have pre-existing cardiac conditions, such as congenital abnormalities, angina pectoris, coronary artery disease and aortopathies, need to undergo multidisciplinary testing, counselling, and optimization before getting pregnant. They also need to be closely monitored and have their medication needs managed. Close monitoring is crucial for patients who developed cardiac conditions like congestive heart failure, preeclampsia, cardiomyopathy, coronary events, or arrhythmia while pregnant. The signs of a cardiac issue during pregnancy include- fatigue, chest pain, shortness of breath, fainting, difficulty breathing while sleeping.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India